Baricitinib Performs Well in Adolescents With Severe AA. Is a Label Update in the Cards?

October 24, 2025

Fall Clinical News: Deuruxolitinib Shows Early and Sustained Efficacy in AA

October 23, 2025

Inside the Alopecia Pipeline: A closer look at Veradermics’ VDPHL01, the potential first and only extended-release oral minoxidil treatment for hair regrowth in women and men

October 20, 2025

TDD Alopecia News Brief: Can a Natural Sweetener Enhance the Delivery of Minoxidil?

October 8, 2025

Topline Phase 3 Data: Upadacitinib (Rinvoq, AbbVie) Continues to Show Promise in Severe AA

August 21, 2025

When Time Is Follicle: Diagnosing Alopecia Areata

August 6, 2025

Upadacitinib (Rinvoq, AbbVie) in Severe AA: Explore the Topline Phase 3 Data

July 31, 2025

U.S. FDA Fast-tracks Nektar Therapeutics’ Rezpegaldesleukin for Severe-to-Very-Severe AA

July 29, 2025

Topical Botanical Shows Promise in AA: Here’s What To Know

July 23, 2025

Sun Pharma Launches Deuruxolitinib (Leqselvi) for Severe Alopecia Areata

July 14, 2025

Low-dose Doxycycline Curbs Symptoms of Lymphocytic Scarring Alopecia, Minus the Side Effects of Higher Doses

March 18, 2025

Lilly’s Baricitinib Yields High Rates of Hair Regrowth in Adolescents with AA: A Q & A With Brittany Craiglow, MD

March 8, 2025